Triclabendazole
70 interactions 4 explained in plain EnglishTriclabendazole is used to treat fascioliasis (an infection, usually in the liver and bile ducts, caused by flat worms [liver flukes]) in adults and children 6 years of age and older. Triclabendazole is in a class of medications called anthelmintics. It works by killing the flat worms. Read the full Triclabendazole drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Triclabendazole Interferon Alfa-2B Injection Intron A® Increased risk of QT interval prolongation Details Triclabendazole Ivabradine Corlanor An increased risk of QT interval prolongation Details Triclabendazole Ketoconazole Topical Extina® Foam An increased risk of QT interval prolongation Details Triclabendazole Lefamulin Xenleta Increased risk of QT interval prolongation Details Triclabendazole Lenvatinib Lenvima Increased risk of QT-interval prolongation Details Triclabendazole Levofloxacin Levaquin An increased risk of QT interval prolongation Details Triclabendazole Levofloxacin Injection Levaquin An increased risk of QT interval prolongation Details Triclabendazole Loperamide Diamode An increased risk of QT interval prolongation, which may increase risk of cardiotoxicity (torsade de pointes, cardiac arrest) Details Triclabendazole Mefloquine Lariam® An increased risk of QT interval prolongation Details Triclabendazole Meloxicam Alloxate Increased meloxicam exposure and reduced meloxicam metabolic clearance Details Triclabendazole Meloxicam Injection Alloxate Increased meloxicam exposure and reduced meloxicam metabolic clearance Details Triclabendazole Metronidazole Flagyl An increased risk of QT interval prolongation Details Triclabendazole Metronidazole Injection Flagyl An increased risk of QT interval prolongation Details Triclabendazole Metronidazole Topical MetroCream® An increased risk of QT interval prolongation Details Triclabendazole Metronidazole Vaginal MetroGel® Vaginal An increased risk of QT interval prolongation Details Triclabendazole Mexiletine Mexitil® Increased risk of QT interval prolongation Details Triclabendazole Moxifloxacin Avelox An increased risk of QT interval prolongation Details Triclabendazole Moxifloxacin Injection Avelox An increased risk of QT interval prolongation Details Triclabendazole Moxifloxacin Ophthalmic Moxeza® An increased risk of QT interval prolongation Details Triclabendazole Nafarelin Nasal Spray Synarel An increased risk of QT interval prolongation Details Triclabendazole Obeticholic Acid Ocaliva Increased risk of QT interval prolongation Details Triclabendazole Octreotide Bynfezia An increased risk of QT interval prolongation Details Triclabendazole Octreotide Injection Bynfezia An increased risk of QT interval prolongation Details Triclabendazole Ofloxacin Floxin® An increased risk of QT interval prolongation Details Triclabendazole Ofloxacin Ophthalmic Ocuflox An increased risk of QT interval prolongation Details Triclabendazole Ofloxacin Otic Floxin® Otic An increased risk of QT interval prolongation Details Triclabendazole Olodaterol Oral Inhalation Striverdi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Triclabendazole Oxaliplatin Injection Eloxatin® Increased risk of QT-interval prolongation Details Triclabendazole Peginterferon Alfa-2A Injection Pegasys Increased risk of QT interval prolongation DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist